newest glp-1 drugs Retatrutide for weight loss: Study shows 30% body weight loss The next generation of GLP-1

Albiglutide 30 mg was administered once weekly and enrolled a total of 9463 subjects aged 40 years with T2DM and established CVD

The 44% reduction in all-cause mortality observed among patients with obesity and co-occurring autoimmune disease is a striking finding that demands our attention, said Fatima Cody Stanford, MD, associate professor of medicine and pediatrics at Harvard Medical School, who was not involved in the study

Diabetes 64 , 25372549 (2015)

So, the scientists went looking for cold-blooded animals instead

But here is where things get complicated with Anthem specifically

Obesity Prevention Management